GO Term | Evidence Code | PMID |
---|---|---|
defense response to virus | ||
regulation of response to type II interferon | ||
positive regulation of transcription, DNA-templated | ||
positive regulation of tyrosine phosphorylation of STAT protein | ||
DNA damage checkpoint signaling |
GO Term | Evidence Code | PMID |
---|---|---|
NAD+ ADP-ribosyltransferase activity | ||
ADP-D-ribose binding | ||
histone binding | ||
NAD+-protein ADP-ribosyltransferase activity | ||
enzyme binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:3571 | liver cancer | |
DOID:3770 | pulmonary fibrosis | |
DOID:399 | tuberculosis | |
DOID:418 | systemic scleroderma | |
DOID:419 | scleroderma | |
DOID:4235 | spindle cell sarcoma | |
DOID:4766 | embryoma | |
DOID:5419 | schizophrenia | |
DOID:552 | pneumonia | |
DOID:5604 | adult acute lymphocytic leukemia |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
108266415 | ICTPU31382 | ||
431935 | Xenbase:XB-GENE-6251556 | ||
100145202 | Xenbase:XB-GENE-1010331 | ||
109322879 | CROPO10347 | ||
113445446 | PSETE18325 | ||
100550752 | MELGA12227 | ||
103814298 | SERCA06593 | ||
100404232 | CALJA11688 | ||
105589780 | CERAT26655 | ||
102139716 | MACFA27851 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024